Alembic Pharmaceuticals Ltd
NSE:APLLTD
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
719.4
1 247.7
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one APLLTD stock under the Base Case scenario is 991.24 INR. Compared to the current market price of 1 028 INR, Alembic Pharmaceuticals Ltd is Overvalued by 4%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Alembic Pharmaceuticals Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for APLLTD cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Alembic Pharmaceuticals Ltd
Balance Sheet Decomposition
Alembic Pharmaceuticals Ltd
Current Assets | 30.8B |
Cash & Short-Term Investments | 1.4B |
Receivables | 10.7B |
Other Current Assets | 18.7B |
Non-Current Assets | 33.7B |
Long-Term Investments | 930.2m |
PP&E | 30.7B |
Other Non-Current Assets | 2B |
Current Liabilities | 14.6B |
Accounts Payable | 7.4B |
Short-Term Debt | 4.3B |
Other Current Liabilities | 2.9B |
Non-Current Liabilities | 1.7B |
Long-Term Debt | 628.8m |
Other Non-Current Liabilities | 1.1B |
Earnings Waterfall
Alembic Pharmaceuticals Ltd
Revenue
|
63B
INR
|
Cost of Revenue
|
-17B
INR
|
Gross Profit
|
46.1B
INR
|
Operating Expenses
|
-39.1B
INR
|
Operating Income
|
7B
INR
|
Other Expenses
|
-660.5m
INR
|
Net Income
|
6.3B
INR
|
Free Cash Flow Analysis
Alembic Pharmaceuticals Ltd
INR | |
Free Cash Flow | INR |
APLLTD Profitability Score
Profitability Due Diligence
Alembic Pharmaceuticals Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Score
Alembic Pharmaceuticals Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
APLLTD Solvency Score
Solvency Due Diligence
Alembic Pharmaceuticals Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.
Score
Alembic Pharmaceuticals Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
APLLTD Price Targets Summary
Alembic Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for APLLTD is 1 158.72 INR with a low forecast of 903.95 INR and a high forecast of 1 482.6 INR.
Dividends
Current shareholder yield for APLLTD is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
APLLTD Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Alembic Pharmaceuticals Ltd. is a research and development pharmaceutical company. The company is headquartered in Vadodara, Gujarat. The company went IPO on 2011-09-17. The firm is engaged in the active pharmaceutical ingredient (API) business and real estate business. Its pharmaceuticals business is engaged in manufacturing and marketing of fermentation and chemistry-based API. The firm is also engaged in research and development activity at Vadodara. The Company’s real estate business is engaged in the construction of residential and commercial real estate projects and project management and marketing consultancy. Its API manufacturing includes estolate, biphenyl valine oxalate, and venlafaxine. Its residential projects include Samsara, Veda, Shangri La, Urban Forest, Veda II, and KIARA. The firm is also engaged power generation through co-generation plants of approximately 11 megawatts. The company has approximately four windmills of total five megawatts. The API manufacturing facility is located at Alembic Road, Vadodara, Gujarat. Its subsidiary is Alembic City Limited.
Contact
IPO
Employees
Officers
The intrinsic value of one APLLTD stock under the Base Case scenario is 991.24 INR.
Compared to the current market price of 1 028 INR, Alembic Pharmaceuticals Ltd is Overvalued by 4%.